Why Oral GLP-1 Drugs Could Change Diabetes Care
GLP-1 medications are currently the talk of the town. If you live with type 2 diabetes, you've probably heard a lot about these and…
This study is for people who are overweight or have obesity with at least one weight-related health condition and do not have Type 2 Diabetes. People with prediabetes may be eligible. The study is testing an investigational once-weekly injection to see if it is safe and effective for weight reduction. Participants will continue their current medications and receive either the study medication or a placebo.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator